Ergomed Plc is a clinical development company. It is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. The firm focuses on the development of oncology, neurology and immunology drugs. It operates its business through following segments: Clinical Research Organization and Pharmacovigilance. The company has two complementary businesses divisions: The Services Business and The Co-Development Business. The Services Business division provides services to the pharmaceutical and biotechnology industry. The Co-Development Business division engages in the drug development services. Ergomed was founded by Miroslav Reljanovic in 1997 and is headquartered in Guildford, the United Kingdom.